Viewing Study NCT04523493


Ignite Creation Date: 2025-12-25 @ 1:20 AM
Ignite Modification Date: 2026-01-02 @ 3:15 AM
Study NCT ID: NCT04523493
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-09
First Post: 2020-07-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase III Study of Toripalimab(JS001) Combined With Lenvatinib for Advanced HCC
Sponsor: Shanghai Junshi Bioscience Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module